Natriuretic Peptides Suppress Vascular Endothelial Cell Growth Factor Signaling to Angiogenesis

A. Pedram
2001 Endocrinology  
Vascular endothelial cell growth factor (VEGF) is essential for angiogenesis. Atrial natriuretic peptide (ANP) inhibits the production of VEGF, but whether this important vascular peptide also inter-rupts VEGF signaling to angiogenesis is unknown. In cultured bovine aortic endothelial cells, VEGF significantly stimulated extracellular signal-regulated protein kinase activity and phosphorylation, which was inhibited 60% by coincubation with ANP or a natriuretic peptide clearance receptor
more » ... ligand (NPRC), C-type NAP-(4 -23) [C-ANP-(4 -23)]. VEGF also stimulated c-Jun N-terminal kinase (JNK) and p38 activities/phosphorylation that were prevented by the two natriuretic peptides (NP). A specific NP guanylate cyclase (GC) receptor antagonist, HS-142-1, blocked the actions of ANP [but not those of C-ANP-(4 -23)], supporting the involvement of both GC and NPRC receptors. VEGF
doi:10.1210/en.142.4.1578 pmid:11250939 fatcat:vux5joneafhxhiebb7fmhczvha